Exploring an orbitrap analyzer for the characterization of intact antibodies by native mass spectrometry

131Citations
Citations of this article
153Readers
Mendeley users who have this article in their library.
Get full text

Abstract

Monoclonal antibodies (mAbs) represent a major class of therapeutic biomolecules being developed by the biopharmaceutical industry, their popularity largely being a result of their high specificity towards targets. Therapeutic mAbs are being developed for various diseases, with a strong focus on cancer and immunological disorders.[1] All antibody drugs currently approved for clinical use are based on the immunoglobulin G (IgG) class; these molecules are composed of two heavy chains and two light chains, connected by disulfide bonds, and with a molecular weight of approximately 150 kDa. Antibody-based biopharmaceuticals can be complex and heterogeneous molecules, and a range of analytical tools are necessary to characterize them fully. © 2012 Wiley-VCH Verlag GmbH & Co. KGaA, Weinheim.

Cite

CITATION STYLE

APA

Rosati, S., Rose, R. J., Thompson, N. J., Van Duijn, E., Damoc, E., Denisov, E., … Heck, A. J. R. (2012). Exploring an orbitrap analyzer for the characterization of intact antibodies by native mass spectrometry. Angewandte Chemie - International Edition, 51(52), 12992–12996. https://doi.org/10.1002/anie.201206745

Register to see more suggestions

Mendeley helps you to discover research relevant for your work.

Already have an account?

Save time finding and organizing research with Mendeley

Sign up for free